Article Information
History
- October 13, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Emma Gerber1,2,
- Meshach Asare-Werehene1,2,3,4,
- Arkadiy Reunov5,
- Dylan Burger1,2,
- Tien Le3,6,
- Euridice Carmona7,
- Anne-Marie Mes-Masson7,8 and
- Benjamin K. Tsang*,1,2,3
- 1Chronic Disease Program, Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON, K1Y 4E9, Canada
- 2Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, K1H 8L1, Canada
- 3Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Faculty of Medicine, University of Ottawa, Ottawa, ON, K1H 8L1, Canada
- 4Centre for Infection, Immunity, and Inflammation, Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, K1N 6N5, Canada
- 5Department of Biology, St. Francis Xavier University, Antigonish, NS, B2G 2W5, Canada
- 6Clinical Epidemiology Program, Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON, K1Y 4E9, Canada
- 7Centre de recherche du CHUM et Institut du cancer de Montréal, Montréal, QC, H2X 0A9, Canada
- 8Département de médecine, l’Université de Montréal, Montréal, QC, H3T 1J4, Canada
- ↵*Correspondence: Dr. Benjamin K Tsang, Chronic Disease Program, Ottawa Hospital Research Institute, The Ottawa Hospital (General Campus), Ottawa, Canada K1H 8L6; Tel: 1-613-798-5555 ext 72926; Email: btsang{at}ohri.ca
Posted October 13, 2022.
Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin
